stage iib prostate cancer
Showing 26 - 39 of 39
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Los Angeles, California
- +14 more
Sep 18, 2017
Prostate Adenocarcinoma, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Philadelphia (radiation, procedure,
Completed
- Prostate Adenocarcinoma
- +3 more
- Copper Cu 64 TP3805
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Cholecalciferol, Genistein,
Completed
- Prostate Adenocarcinoma
- +3 more
- Cholecalciferol
- +4 more
-
Birmingham, Alabama
- +10 more
Jun 20, 2016
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Ann Arbor (cilengitide)
Completed
- Recurrent Prostate Cancer
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Mar 28, 2016
Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Bicalutamide, Goserelin
Completed
- Recurrent Prostate Carcinoma
- +4 more
- Bicalutamide
- +4 more
-
Jacksonville, Florida
- +6 more
Jun 3, 2015
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer Trial in Sacramento (perifosine, laboratory
Terminated
- Adenocarcinoma of the Prostate
- +4 more
- perifosine
- laboratory biomarker analysis
-
Sacramento, CaliforniaUC Davis Cancer Center
Feb 9, 2015
Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide
Terminated
- Diarrhea
- +7 more
- cabazitaxel
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Nov 21, 2014
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Philadelphia (lapatinib ditosylate,
Completed
- Recurrent Prostate Cancer
- +4 more
- lapatinib ditosylate
- laboratory biomarker analysis
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Sep 19, 2014
Adenocarcinoma of the Prostate, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Los Angeles (diffusion-weighted
Completed
- Adenocarcinoma of the Prostate
- +2 more
- diffusion-weighted magnetic resonance imaging
- laboratory biomarker analysis
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Sep 9, 2014
Bone Metastases, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Boston (procedure, radiation, other)
Completed
- Bone Metastases
- +6 more
- magnetic resonance imaging
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 1, 2014
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial (atorvastatin calcium, )
Withdrawn
- Recurrent Prostate Cancer
- +5 more
- atorvastatin calcium
- placebo
- (no location specified)
Jun 17, 2013
Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Denver (drug, procedure, other)
Completed
- Stage I Prostate Cancer
- +2 more
- bromodeoxyuridine
- +2 more
-
Denver, ColoradoUniversity of Colorado
Jan 24, 2013
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Philadelphia (motexafin lutetium,
Terminated
- Adenocarcinoma of the Prostate
- +4 more
- motexafin lutetium
- photodynamic therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jan 15, 2013
Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Cleveland (dietary supplement, other,
Terminated
- Stage I Prostate Cancer
- +2 more
- defined green tea catechin extract
- +7 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Mar 14, 2012